10.27.2008 - Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA
10.23.2008 - Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
10.21.2008 - Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
10.20.2008 - FDA Defers Final Action on milnacipran New Drug Application
10.07.2008 - Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
10.01.2008 - Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
09.30.2008 - Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
09.23.2008 - Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
09.15.2008 - Forest Laboratories, Inc. Appoints Frank Murdolo, Vice President - Investor Relations
09.04.2008 - USPTO Office Action in the Reexamination of U.S. Patent No. 6,545,040
09.03.2008 - Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
07.30.2008 - New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
07.22.2008 - Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Agreement Termination
06.30.2008 - Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
06.19.2008 - Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
05.20.2008 - Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
05.20.2008 - Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
05.15.2008 - Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
05.12.2008 - Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
05.07.2008 - Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
04.15.2008 - Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
04.07.2008 - Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings
03.19.2008 - Forest Laboratories Announces Resignation of Ivan Gergel, MD
03.04.2008 - Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
02.27.2008 - Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
02.21.2008 - Forest and Cypress Announce FDA Acceptance for Review of
New Drug Application for Milnacipran for the Treatment of Fibromyalgia
02.05.2008 - Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
01.25.2008 - Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
01.22.2008 - Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
01.15.2008 - Forest Laboratories, Inc. Reports Q3'08 Diluted Earnings Per Share of $0.96. Raises FY2008 EPS Guidance Range to $3.35-$3.45 Excluding $0.15 per Share Licensing Charge
01.10.2008 - Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
01.04.2008 - Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings